You are here

Article Text

Article menu
Download PDFPDF
Editorial
Management of orbital inflammation
  1. Brett O'Donnell
  1. Correspondence to Dr Brett A O'Donnell, North Shore Medical Centre, Level 2, suite 3, 66 Pacific Hwy, St Leonards 2065, NSW Australia; brett.odonnell{at}island.net.au

https://doi.org/10.1136/bjo.2011.203513

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The authors Bijlsma, Paridaens and Kalmann are to be commended for their excellent work on the treatment of idiopathic orbital inflammation (IOI) presented in this issue of the journal (see page 1068).1 Although it is retrospective, their study is one of the few comparison case series on the treatment of this condition. The disease is relatively uncommon and hence this series is small despite its multi-centre patient source.

    Steroids remain the drug of choice for IOI on the basis of cost, availability, easy oral administration and patient response. Interestingly, the literature on the treatment of IOI lacks randomised controlled trials on …

    View Full Text

    Footnotes

    • Linked article 195552.

    • Competing interests None.

    • Provenance and peer review Commissioned; not externally peer reviewed.

    Linked Articles